Jan 20, 2023
Neosoma HGG's (NS-HGlio) Technology and Development was Recently Published in Neuro-Oncology Advances
We are proud to announce that the technology and development of Neosoma HGG (NS-HGlio) was recently published in Neuro-Oncology Advances, a high-impact peer-reviewed journal of the Society of Neuro-Oncology.
Aly Abayazeed, MD, Neosoma's Co-Founder and Chief Medical Officer, served as primary author on the paper, with contributions from multiple additional authors.
Our commitment to quality research and peer reviewed publications ensures transparency and confidence in our technologies.
Neosoma is incredibly grateful to our patients and everyone involved in this project, without whose hard work and dedication this publication would not have been possible.
Read the full paper here.